Skip to the main content.
Request Demo

1 min read

Drug Channels: How Patient Engagement Can Reduce Brand Launch Risk

Drug Channels: How Patient Engagement Can Reduce Brand Launch Risk

Manufacturers only have one chance to gain provider acceptance for a new specialty drug. With so many challenges that may decrease the real-world performance of the medication, CareMetx Chief Patient Experience Officer Jessica Lens explains that patient engagement is a critical factor ensuring the success of new drug launches.

Access and affordability are typically more central to the design of patient services programs. Prioritizing patient adherence to therapy regimens, particularly for complex medications, can mitigate the risks of patients stopping their treatment. “While the importance of integrating adherence into patient services programs is widely acknowledged in theory,” Lens explains, “the practical application of this understanding is often lacking, resulting in programs that do not fully facilitate optimal medication use.”

However, adherence contributes to better patient experiences, better health outcomes, and ultimately brand success. "How Patient Engagement Can Reduce Brand Launch Risk" explores this topic in more depth while also discussing strategies to help manufacturers evaluate hub vendors on adherence.

Go to article.

 

Navigating Brand Launch Risks: Can Patient Engagement Help?

Navigating Brand Launch Risks: Can Patient Engagement Help?

Drawing on over 11 years of experience in supporting patient services programs, CareMetx has consistently observed a pivotal insight: programs that...

Read More
Inside Nonadherence: Examining Technology’s Role

Inside Nonadherence: Examining Technology’s Role

It may seem like a logical assumption that once an ill patient is diagnosed and put on a care plan to treat their illness, said patient will...

Read More
Case Study: CareMetx Boosts Adherence and Persistence for Oral Oncology Therapy by Addressing Patient Journey Barriers

Case Study: CareMetx Boosts Adherence and Persistence for Oral Oncology Therapy by Addressing Patient Journey Barriers

This leading pharmaceutical manufacturer contracted with CareMetx for an integrated patient support program to boost adherence and persistence for an...

Read More